Skip to main content

US

Androgen receptor (AR)/miR-520f-3p/SOX9 signaling is involved in the altering hepatocellularcarcinoma (HCC) cell sensitivity to the Sorafenib therapy under hypoxia via increasing cancerstem cells phenotype.

By

Read more about Androgen receptor (AR)/miR-520f-3p/SOX9 signaling is involved in the altering hepatocellularcarcinoma (HCC) cell sensitivity to the Sorafenib therapy under hypoxia via increasing cancerstem cells phenotype.

Xiao Y, Sun Y, Liu G, Zhao J, Gao Y, Yeh S, Gong L, Chang C